PGP and breast carcinoma: By screening different breast cancer cell lines, we found that TNBC human and murine doxorubicin-resistant/Pgp-positive cells did not induce C/EBP-β LIP in response to doxorubicin, differently from doxorubicin-sensitive/Pgp-negative cells.